NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,287,119 | -8.5% | 7,197,983 | -11.7% | 0.00% | 0.0% |
| Q2 2023 | $4,687,809 | -41.9% | 8,149,876 | -29.0% | 0.00% | -42.9% |
| Q1 2023 | $8,071,419 | -77.2% | 11,483,026 | -26.7% | 0.01% | -78.1% |
| Q4 2022 | $35,389,460 | -32.7% | 15,659,053 | -4.6% | 0.03% | -37.3% |
| Q3 2022 | $52,552,000 | -16.4% | 16,422,443 | -0.8% | 0.05% | -8.9% |
| Q2 2022 | $62,895,000 | -31.6% | 16,551,322 | -3.0% | 0.06% | -18.8% |
| Q1 2022 | $91,963,000 | -60.9% | 17,061,822 | -2.0% | 0.07% | -57.7% |
| Q4 2021 | $235,242,000 | -27.1% | 17,412,422 | -3.2% | 0.16% | -28.5% |
| Q3 2021 | $322,912,000 | +4.1% | 17,979,522 | -0.6% | 0.23% | +9.6% |
| Q2 2021 | $310,283,000 | -14.6% | 18,081,772 | -0.5% | 0.21% | -17.8% |
| Q1 2021 | $363,307,000 | +15.9% | 18,165,369 | -1.5% | 0.25% | +8.6% |
| Q4 2020 | $313,487,000 | +0.2% | 18,440,399 | -2.3% | 0.23% | -9.7% |
| Q3 2020 | $312,997,000 | -30.4% | 18,866,629 | -2.8% | 0.26% | -33.2% |
| Q2 2020 | $449,457,000 | +22.9% | 19,406,599 | -5.3% | 0.39% | +7.5% |
| Q1 2020 | $365,620,000 | -15.6% | 20,482,919 | +2.0% | 0.36% | +14.3% |
| Q4 2019 | $433,434,000 | +24.4% | 20,080,348 | +5.0% | 0.31% | +12.5% |
| Q3 2019 | $348,329,000 | -48.7% | 19,123,222 | +0.2% | 0.28% | -44.4% |
| Q2 2019 | $679,237,000 | +4.4% | 19,090,422 | -1.4% | 0.50% | +4.8% |
| Q1 2019 | $650,356,000 | +2.0% | 19,355,822 | -0.2% | 0.48% | -7.4% |
| Q4 2018 | $637,679,000 | -48.1% | 19,400,022 | -3.7% | 0.52% | -37.6% |
| Q3 2018 | $1,228,644,000 | +20.4% | 20,154,922 | -3.6% | 0.83% | +9.5% |
| Q2 2018 | $1,020,690,000 | -54.4% | 20,902,922 | -0.8% | 0.76% | -54.9% |
| Q1 2018 | $2,238,037,000 | +67.6% | 21,061,895 | -5.8% | 1.68% | +63.8% |
| Q4 2017 | $1,335,191,000 | +140.4% | 22,357,522 | -3.4% | 1.02% | +122.8% |
| Q3 2017 | $555,413,000 | +22.9% | 23,142,222 | +0.1% | 0.46% | +18.6% |
| Q2 2017 | $452,041,000 | -10.2% | 23,122,286 | +7.8% | 0.39% | -15.1% |
| Q1 2017 | $503,513,000 | +91.4% | 21,453,485 | +0.1% | 0.46% | +76.4% |
| Q4 2016 | $263,022,000 | -23.5% | 21,436,186 | +7.1% | 0.26% | -24.5% |
| Q3 2016 | $343,714,000 | +20.8% | 20,006,621 | +0.0% | 0.34% | +13.2% |
| Q2 2016 | $284,637,000 | +3.5% | 20,002,586 | -0.0% | 0.30% | +6.3% |
| Q1 2016 | $275,139,000 | -17.5% | 20,010,086 | +1.1% | 0.28% | -16.4% |
| Q4 2015 | $333,365,000 | +54.1% | 19,784,286 | +0.2% | 0.34% | +42.1% |
| Q3 2015 | $216,393,000 | -12.2% | 19,743,886 | +0.2% | 0.24% | -0.8% |
| Q2 2015 | $246,533,000 | +14.6% | 19,706,886 | +0.8% | 0.24% | +15.2% |
| Q1 2015 | $215,078,000 | -23.9% | 19,552,586 | +7.3% | 0.21% | -26.6% |
| Q4 2014 | $282,500,000 | +29.0% | 18,225,786 | +0.5% | 0.29% | +22.2% |
| Q3 2014 | $218,923,000 | +8.1% | 18,137,786 | +14.8% | 0.23% | +5.4% |
| Q2 2014 | $202,611,000 | +7.6% | 15,804,286 | +1.7% | 0.22% | +4.2% |
| Q1 2014 | $188,273,000 | +32.7% | 15,534,086 | +24.3% | 0.21% | +25.3% |
| Q4 2013 | $141,857,000 | +36.5% | 12,498,386 | +25.6% | 0.17% | +24.1% |
| Q3 2013 | $103,918,000 | +18.8% | 9,953,856 | +31.4% | 0.14% | +9.6% |
| Q2 2013 | $87,490,000 | – | 7,574,856 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |